The invention belongs to the technical field of
analytical chemistry, and particularly relates to a method for simultaneously determining the concentrations of eight
antituberculous drugs in
plasma by adopting a liquid
chromatography-
mass spectrometry method, wherein the eight
antituberculous drugs comprise rifudine, chlorphenazine,
levofloxacin,
clarithromycin, sulfimide, p-
aminosalicylic acid,
moxifloxacin and
amikacin. According to the method, the characteristics of hydrophilic and hydrophobic compounds are considered,
protein precipitation is carried out by utilizing ACN:MEOH:45%TCA, the extraction rate of the hydrophilic compound AMK is improved, 20% of ACN, 0.2% of FA and 1% of HFBA are used as diluents, and the
retention time of the hydrophilic compound AMK is prolonged by adding the HFBA. The method is high in sensitivity, strong in specificity and wide in
linear range, can be used for qualitative and quantitative analysis of to-be-detected substances with unknown concentrations in
plasma of
tuberculosis patients, is simple and rapid to operate, does not need an extraction and volatilization process, and can meet the characteristics of urgent
clinical treatment drug monitoring tasks and high requirements on detection time. The detection
system provided by the invention provides a new technical platform for
tuberculosis patient treatment drug monitoring, and is easy to popularize and apply.